Thalidomide-O-amido-C4-NH2 (TFA), 100mg

(3,6-Dimethoxypyridazin-4-yl)methanol, 98%, 250mg

2-Amino-3-(1H-indol-3-yl)-2-methylpropanoic acid, 95.0%, 5g

tert-Butyl 4-(4-nitro-1H-pyrazol-1-yl)piperidine-1-carboxylate, 97%, 1g

4,5,6-Triaminopyrimidine Sulfate>98.0%(HPLC)1g

2,5-Dimethyl-1-(4-nitrophenyl)-1H-pyrrole, 98%, 5g

1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane, 95.0%, 1g

3-Bromo-1,10-phenanthroline, 95.0%, 5g

(2S)-2-[(tert-Butoxycarbonyl)amino]pentanoic acid, 98.0%, 25g

(S)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 100mg

Fmoc-Nva-OH, 98%, 100g

4-(2-Methyl-imidazol-1-yl)-benzaldehyde, 95.0%, 5g

2-methyl-3'-morpholinomethyl benzophenone, 97.0%, 1g